Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 291 participants.

Also called NCT01515228

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 291 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01515228
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01515228. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)
Intervention (Device)
Xience Prime
Intervention (Device)
Cilotax stent
Lead sponsor
CHEOL WHAN LEE, MD, PhD. (class: other)
Collaborator
CardioVascular Research Foundation, Korea (class: other)

Record details

Record id
cardio:ct-nct01515228
Content hash
6518fb9d19caa075704da65ff192abdbcc6841ae8c772108c7820e8744ea81c2